Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

Eton Pharmaceuticals, Inc. ETON

· Materials · Pharmaceutical Preparations

FY2025 10-K, filed 2026-03-19
SEC EDGAR

Filing evidence summary

Mixed evidenceCoverage 5/5 core metrics

Flagged areas: Solvency & liquidity.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • 3 filing risk checks flagged

    Flagged areas: Solvency & liquidity.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

  • Revenue expanded

    Latest reported annual revenue changed +104.9% from the prior reported annual observation.

    Why this surfaced

    Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.

  • Operating margin improved

    Operating margin changed +5.6 percentage points from the prior annual period.

    Why this surfaced

    Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.

  • Free cash flow was positive

    Latest reported free cash flow was $10M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.

Core trend metrics

Latest annual revenue growth
+104.9%
as of 2025-12-31
Latest annual operating margin
-1.1%
as of 2025-12-31
Free cash flow
$10M
as of 2025-12-31
Debt / equity
0.83x
as of 2025-12-31
ROIC snapshot
-1.0%
period varies

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

3of 10 rule-based checks flagged
  • Solvency & liquidity

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-09-06
Latest period end
2025-12-31
Filings
EDGAR ↗

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2025-12-3110-K filed 2026-03-19prior period 2024-12-31 from the same filingView filing
By product or service
Revenue
  • Product Sales And Royalties$76.7M
    95.9%
    +99.1% yoy
  • License$3.29M
    4.1%
    +557.2% yoy

Members sum to the consolidated $80M for this period.

Latest quarter
Quarter ending 2026-03-3110-Q filed 2026-05-14prior period 2025-03-31 from the same filingView filing
  • Product Sales And Royalties$24.3M
    100.0%
    +73.4% yoy
  • License$0
    0.0%
    -100.0% yoy

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

Peer percentiles

latest fiscal year ending 2025-12-31 · among 4,121 US-listed filers · 796 in Materials
MetricValuevs all filersvs sector
Revenue
latest fiscal-year revenue as filed
$80M
25thof 3,301
bottom third
43rdof 522
middle third
Revenue growth
latest fiscal-year revenue vs the prior fiscal year
104.9%
95thof 3,135
top third
86thof 473
top third
Gross margin
gross profit ÷ revenue
53.5%
69thof 1,603
top third
72ndof 221
top third
Operating margin
operating income ÷ revenue
-1.1%
41stof 2,819
middle third
63rdof 483
middle third
Net margin
net income ÷ revenue
-5.8%
34thof 3,263
middle third
56thof 518
middle third
Free-cash-flow margin
(operating cash flow − |capex|) ÷ revenue
12.8%
72ndof 2,679
top third
82ndof 433
top third
Return on equity
net income ÷ stockholders' equity (positive equity only)
-17.6%
29thof 3,577
bottom third
62ndof 701
middle third
Stock comp ÷ revenue
stock-based compensation ÷ revenue · lower is ranked higher
6.9%
30thof 2,895
bottom third
52ndof 476
middle third
Days sales outstanding
receivables ÷ revenue × 365 · lower is ranked higher
54 days
44thof 2,398
middle third
48thof 387
middle third
Net debt ÷ operating cash flow
net debt ÷ operating cash flow (OCF > 0) · lower is ranked higher
-0.4×
85thof 1,547
top third
89thof 145
top third
Cash-flow accrual ratio
(net income − operating cash flow) ÷ average total assets · lower is ranked higher
-18.0%
87thof 3,545
top third
82ndof 661
top third
Balance-sheet accrual ratio
change in net operating assets ÷ average net operating assets · lower is ranked higher
-56.5%
91stof 3,029
top third
82ndof 582
top third

Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.

Earnings quality

latest fiscal year ending 2025-12-31 · accruals and cash conversion as filed
Cash conversion
-
operating cash flow ÷ net income, latest fiscal year
Cash-flow accrual ratio
-18.0%
(net income − operating cash flow) ÷ average total assets
Balance-sheet accrual ratio
-56.5%
change in net operating assets ÷ average net operating assets
Cash-backed years
4 of 5
fiscal years where operating cash flow met or exceeded net income
Mean cash conversion
-
across the stored fiscal years with positive net income

Per fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.

Point-in-time ledger

first-reported vs latest filing · periods since 2020-01-01 · 21 changed periods
Line itemPeriodFirst reportedLatest filingChangeFilings
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2024-03-3125,763 shares
10-Q 2024-05-09
25,763,337 shares
10-Q 2025-05-13
+99901.3%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2022-06-3025,126 shares
10-Q 2022-08-11
25,126,000 shares
10-Q 2023-08-10
+99900.0%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2024-09-3026,550 shares
10-Q 2024-11-12
26,550,000 shares
10-Q 2025-11-06
+99900.0%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2022-06-3025,126 shares
10-Q 2022-08-11
25,126,000 shares
10-Q 2023-08-10
+99900.0%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2024-06-3025,778 shares
10-Q 2024-08-08
25,778,000 shares
10-Q 2025-08-07
+99900.0%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2024-09-3025,900 shares
10-Q 2024-11-12
25,900,000 shares
10-Q 2025-11-06
+99900.0%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2021-06-3025,211,277 shares
10-Q 2021-08-16
25,211 shares
10-Q 2022-08-11
-99.9%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2023-06-3025,983,000 shares
10-Q 2023-08-10
25,983 shares
10-Q 2024-08-08
-99.9%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2023-09-3025,719,000 shares
10-Q 2023-11-09
25,719 shares
10-Q 2024-11-12
-99.9%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2021-06-3025,211,277 shares
10-Q 2021-08-16
25,211 shares
10-Q 2022-08-11
-99.9%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2023-03-3125,525,000 shares
10-Q 2023-05-11
25,525 shares
10-Q 2024-05-09
-99.9%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2023-06-3025,593,000 shares
10-Q 2023-08-10
25,593 shares
10-Q 2024-08-08
-99.9%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2023-09-3025,719,000 shares
10-Q 2023-11-09
25,719 shares
10-Q 2024-11-12
-99.9%first · latest
Interest expense
InterestExpense
quarter 2023-09-30$805K
10-Q 2023-11-09
$267K
10-Q 2024-11-12
-66.8%first · latest
Gross profit
GrossProfit
fiscal year 2020-12-31-$247K
10-K 2021-03-16
-$397K
10-K 2023-03-16
-60.7%first · latest · 3 filings carry it
Gross profit
GrossProfit
quarter 2021-09-30$158K
10-Q 2021-11-16
$121K
10-Q 2022-11-10
-23.4%first · latest
Stockholders' equity
StockholdersEquity
balance at 2020-12-31$15.7M
10-K 2021-03-16
$17.6M
10-K 2025-03-18
+12.6%first · latest · 11 filings carry it
Gross profit
GrossProfit
quarter 2022-03-31$1.46M
10-Q 2022-05-12
$1.33M
10-Q 2023-05-11
-9.0%first · latest
Depreciation and amortization
DepreciationAndAmortization
quarter 2024-03-31$252K
10-Q 2024-05-09
$234K
10-Q 2025-05-13
-7.1%first · latest
Gross profit
GrossProfit
quarter 2021-06-30$2.93M
10-Q 2021-08-16
$2.89M
10-Q 2022-08-11
-1.3%first · latest
Gross profit
GrossProfit
fiscal year 2021-12-31$19.2M
10-K 2022-03-16
$19M
10-K 2024-03-14
-1.1%first · latest · 3 filings carry it

First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.

Notes by disclosure type

Not available for ETON yet: no footnote text blocks on file for this filer in the ingested DERA files.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.